Shelby Derene Reed, PhD

Professor in Population Health Sciences
Professor in Medicine
Associate of the Duke Initiative for Science & Society
Member in the Duke Clinical Research Institute
Member of the Duke Cancer Institute
Campus mail Duke Box 17969, #6044 North Pavilion, Durham, NC 27715
Phone (919) 668-8991
Email address shelby.reed@duke.edu

Shelby D. Reed, PhD, is a professor in medicine at the Duke University School of Medicine. She works primarily at the Duke Clinical Research Institute. Dr. Reed holds a PhD in pharmaceutical health services research from the University of Maryland School of Pharmacy and completed a 2-year postdoctoral fellowship in the Pharmaceutical Outcomes Research and Policy Program and the Center for AIDS Research at the University of Washington. Dr. Reed has nearly 20 years of experience in economic evaluation, health services research and health policy. Dr. Reed has extensive expertise in designing and conducting trial-based and model-based cost-effectiveness analyses of medical diagnostics and interventions in numerous therapeutic areas. She was a member of the ISPOR Task Forces that published recommendations for Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials in 2005 and 2015. She has led a wide range of economic and epidemiological studies using secondary data from health care claims, clinical trials, surveys and disease registries. In her evaluations of health policy issues, she has developed computer models to analyze the potential economic impact of trends in clinical trial design, changes in reimbursement policies, financial incentives and the regulatory process in the development of orphan drugs, and the societal value of alternative approaches to identifying drug safety problems. 

Areas of expertise: Health Economics, Health Measurement, Health Policy, and Health Services Research

Education and Training

  • Ph.D., University of Maryland, College Park, 1998

Grants

Publications

Shelby, RA, Dorfman, CS, Bosworth, HB, Keefe, F, Sutton, L, Owen, L, Erkanli, A, Reed, SD, Arthur, SS, Somers, T, Barrett, N, Huettel, S, Gonzalez, JM, and Kimmick, G. "Testing a behavioral intervention to improve adherence to adjuvant endocrine therapy (AET)." Contemporary Clinical Trials (November 22, 2018).

PMID
30472215
Full Text

Dinan, MA, Li, Y, Reed, SD, and Ann Sosa, J. "INITIAL ADOPTION OF RECOMBINANT HUMAN THYROID STIMULATING HORMONE FOLLOWING THYROIDECTOMY IN THE MEDICARE THYROID CANCER PATIENT POPULATION." Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists (November 2018).

PMID
30383499
Full Text

Reed, SD, Li, Y, Dakin, H, Becker, F, Leal, J, Gustavson, SM, Kartman, B, Wittbrodt, E, Mentz, RJ, Pagidipati, NJ, Bethel, MA, Gray, AM, Holman, RR, and Hernandez, AF. "Impact of exenatide on medical costs and health utilities in type 2 diabetes: experience from EXSCEL." 54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD). Berlin, GERMANY. October 1, 2018 - October 5, 2018.: SPRINGER, October 1, 2018.

Scholars@Duke

Becker, F, Dakin, H, Reed, SD, Li, Y, Leal, J, Gustavson, SM, Kartman, B, Wittbrodt, E, Gray, AM, Hernandez, AF, and Holman, RR. "Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial." 54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD). Berlin, GERMANY. October 1, 2018 - October 5, 2018.: SPRINGER, October 1, 2018.

Scholars@Duke

Alfredsson, J, Green, JB, Stevens, SR, Reed, SD, Armstrong, PW, Angelyn Bethel, M, Engel, SS, McGuire, DK, Van de Werf, F, Hramiak, I, White, HD, Peterson, ED, Holman, RR, and TECOS Study Group, . "Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS." Diabetes, Obesity & Metabolism 20, no. 10 (October 2018): 2379-2388.

PMID
29923323
Full Text

Luo, N, O'Connor, CM, Cooper, LB, Sun, J-L, Coles, A, Reed, SD, Whellan, DJ, Piña, IL, Kraus, WE, and Mentz, RJ. "Relationship between changing patient-reported outcomes and subsequent clinical events in patients with chronic heart failure: insights from HF-ACTION." European Journal of Heart Failure (August 31, 2018).

PMID
30168635
Full Text

Wolka, AM, Fairchild, AO, Reed, SD, Anglin, G, Johnson, FR, Siegel, M, and Noel, R. "Effective Partnering in Conducting Benefit-Risk Patient Preference Studies: Perspectives From a Patient Advocacy Organization, a Pharmaceutical Company, and Academic Stated-Preference Researchers." Therapeutic Innovation & Regulatory Science 52, no. 4 (July 2018): 507-513.

PMID
29714550
Full Text

Reed, SD, Li, Y, Leal, J, Radican, L, Adler, AI, Alfredsson, J, Buse, JB, Green, JB, Kaufman, KD, Riefflin, A, Van de Werf, F, Peterson, ED, Gray, AM, Holman, RR, and TECOS Study Group, . "Longitudinal medical resources and costs among type 2 diabetes patients participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)." Diabetes, Obesity & Metabolism 20, no. 7 (July 2018): 1732-1739.

PMID
29573215
Full Text

Campbell, B, Yang, J, Gonzalez, J, Reed, S, Havrilesky, L, Johnson, F, and Hwang, E. "Patient Preferences for Health States Following Alternative Management Options for Ductal Carcinoma in Situ." May 2018.

Full Text

Johnson, F, Disantostefano, R, Reed, S, Yang, J, and Levitan, B. "Something is Better Than Nothing: The Value of Active Intervention on Stated Preferences for Treatments to Delay Onset of Alzheimer’s Disease Symptoms." May 2018.

Full Text

Pages